| Literature DB >> 33984670 |
Antonio Esposito1, Anna Palmisano2, Roberta Cao2, Paola Rancoita3, Giovanni Landoni4, Daniele Grippaldi2, Edda Boccia5, Michele Cosenza2, Antonio Messina2, Salvatore La Marca2, Diego Palumbo2, Clelia Di Serio6, Marzia Spessot7, Moreno Tresoldi8, Paolo Scarpellini9, Fabio Ciceri10, Alberto Zangrillo4, Francesco De Cobelli2.
Abstract
BACKGROUND: The aim of this study was to quantify COVID-19 pneumonia features using CT performed at time of admission to emergency department in order to predict patients' hypoxia during the hospitalization and outcome.Entities:
Keywords: Artificial intelligence; Covid-19; Outcome; Pneumonia; Quantitative CT
Year: 2021 PMID: 33984670 PMCID: PMC8081746 DOI: 10.1016/j.clinimag.2021.04.033
Source DB: PubMed Journal: Clin Imaging ISSN: 0899-7071 Impact factor: 1.605
Fig. 1Flowchart of patient selection. Abbreviations: CT = computed tomography; RT-PCR = real time polymerase chain reaction.
Fig. 2HU density values extraction. An experienced radiologist segmented the well-aerated parenchyma (lime), ground glass opacities (orange), semi-consolidation (red) and consolidation (plum) on chest CT scan of a subset of 35 randomly selected patients with COVID-19 pneumonia. Two examples of manual segmentation are reported on the left. HU values of each pneumonia lesion features and well-aerated parenchyma were extracted using a pixel-by-pixel approach and Gaussian curves of HU values distribution were created (on the right). Intersection points of Gaussian curves identified the following HU threshold values: - 780 HU as threshold between well-aerated parenchyma and GGO; −570 HU as threshold between GGO and semi-consolidation; −290 as threshold between semi-consolidation and consolidation. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3Automatic segmentation of both lungs with quantitative extraction of well-aerated parenchyma, ground glass opacities, semi-consolidation and consolidation. This figure reports the coronal images (on top) and the corresponding 3D volume rendering (bottom), obtained during post-processing performed using a dedicated software (IntelliSpace Portal v.8.0, Philips Medical Systems, Eindhoven, The Netherlands). The software performs a fully automatic segmentation of both lungs from native CT dataset (A). After visual check and manual correction of any segmentation error, the HU thresholds calculated as in Fig. 2 were applied in a multistep fashion analysis. In the first step (B) consolidation pattern was extracted from total lung volume applying the threshold -290HU. In the second step (C) consolidation plus semi-consolidation were extracted from total lung volume applying the threshold -570HU. In the final step (D) consolidation, semi-consolidation and ground glass opacities were extracted from total lung volume applying the threshold -780HU and the red volume (D) represent the well-aerated parenchyma. Hence, consolidation volume was obtained subtracting red volume in B from total lung volume (A); semi-consolidation volume was obtained subtracting red volume in C from red volume in B; ground glass volume was obtained subtracting red volume in D from red volume in C. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Clinical, demographics and CT qualitative features of the study population.
| Overall ( | |
|---|---|
| Age, y.o. | 56 [IQR, 48–71] |
| Sex, M | 51 |
| Comorbidities | |
| Cardiovascular | 38 (49%) |
| Respiratory | 4 (5%) |
| Oncological | 14 (18%) |
| Neurological | 3 (4%) |
| Chronic kidney failure | 1 (1%) |
| Obesity | 7 (9%) |
| Immunodepression | 5 (6%) |
| Diabetes | 15 (19%) |
| Symptoms, n (%) | |
| Fever | 72 (94%) |
| Cough | 45 (58%) |
| Dyspnea | 22 (29%) |
| Asthenia | 6 (8%) |
| Diarrhea | 4 (5%) |
| Other | 8 (10%) |
| Symptom onset, days | 7 [IQR, 4–10] |
| White blood count, ×109/L | 6 [IQR, 4.68–8.68] |
| Lymphocyte count, ×109/L | 1.2 [IQR, 0.8–16.7] |
| CRP, mg/L | 2.1 [IQR, 0.85–3.9] |
| Body temperature, °C | 38 [IQR, 37.5–39] |
| O2 Saturation, % | 93 [IQR, 89–96] |
| CT features | |
| CT typical pattern, n (%) | 69 (90%) |
| CT indeterminate pattern, n (%) | 5 (6%) |
| CT atypical pattern, n (%) | 3 (4%) |
| Peripheral distribution, n (%) | 74 (96%) |
| > 3 lobes involved, n (%) | 68 (88%) |
| Pulmonary fibrosis, n (%) | 7 (9%) |
| Lymph adenomegaly, n (%) | 20 (26%) |
| Pleural effusion, n (%) | 5 (6%) |
| Emphysema, n (%) | 6 (8%) |
Fig. 4ROC curves of CT quantitative features of lung involvement in patients' suffering from COVID-19 pneumonia in predicting oxygen saturation (A), hypoxemia at hospital arrival (B) and during hospitalization (C) and patients ‘outcome (D). GGO had the worst AUCs, and was found as predictor neither of oxygen saturation (AUC 0.51), hypoxemia at time of admission (AUC 0.51) and during the hospitalization (AUC 0.59) nor of patients’ outcome (AUC 0.59).
ROC curves of quantitative parameters of lung involvement on CT at hospital admission in the prediction of patients' hypoxia and hospital discharging.
| Parameters | AUC | Cut-off | Sensitivity | Specificity | Accuracy |
|---|---|---|---|---|---|
| SatO2 < 90% at admission | |||||
| Aerated lung ratio | 0.71 (0.58,84) | ≤57 | 16/23 (70) [47,87] | 33/54 (61) [47,74] | 49/77 (64) [52,74] |
| GGO ratio | 0.51 (0.37,0.65) | ≥10 | 16/23 (70) [47,87] | 24/54 (44) [31,59] | 40/77 (52) [40,63] |
| Semi-consolidation ratio | 0.70 (0.56,0.83) | ≥23 | 13/23 (57) [34,77] | 43/54 (80) [66,89] | 56/77 (73) [61,82] |
| Consolidation ratio | 0.75 (0.62,0.88) | ≥11 | 16/23 (70) [47,87] | 37/54 (69) [54,80] | 53/77 (69) [57,79] |
| pO2 < 60 mm Hg at admission | |||||
| Aerated lung ratio | 0.66 (0.53,0.80) | ≤57 | 18/26 (69) [48,86] | 27/46 (59) [43,73] | 45/72 (62) [50,74] |
| GGO ratio | 0.51 (0.37,0.65) | ≥12 | 13/26 (50) [30,70] | 24/46 (52) [37,67] | 37/72 (51) [39,63] |
| Semi-consolidation ratio | 0.68 (0.55,0.82) | ≥17 | 18/26 (69) [48,86] | 28/46 (61) [45,75] | 46/72 (64) [52,75] |
| Consolidation ratio | 0.70 (0.57,0.83) | ≥9 | 20/26 (77) [56,91] | 28/46 (61) [45,75] | 48/72 (67) [55,77] |
| pO2 < 60 mm Hg during hospitalization | |||||
| Aerated lung ratio | 0.76 (0.65;0.87) | ≤57 | 25/34 (74) [56,87] | 26/38 (68) [51,82] | 51/72 (71) [59,81] |
| GGO ratio | 0.59 (0.45;0.72) | ≥12 | 17/34 (50) [32,68] | 25/38 (66) [49,80] | 42/72 (58) [46,70] |
| Semi-consolidation ratio | 0.75 (0.63;0.86) | ≥17 | 24/34 (71) [53,85] | 25/38 (66) [49,80] | 49/72 (68) [56,79] |
| Consolidation ratio | 0.77 (0.65;0.88) | ≥9 | 25/34 (74) [56,87] | 25/38 (66) [49,80] | 50/72 (69) [57,80] |
| ROC curve analysis predicting discharged vs dead patients | |||||
| Aerated lung ratio | 0.66 (0.50;0.82) | ≥45 | 40/49 (82) [68,91] | 7/12 (58) [28,85] | 47/61 (77) [65,87] |
| GGO ratio | 0.59 (0.42;0.77) | ≤10 | 30/49 (61) [46,75] | 7/12 (58) [28,85] | 37/61 (61) [47,73] |
| Semi-consolidation ratio | 0.62 (0.45;0.79) | ≤17 | 30/49 (61) [46,75] | 7/12 (58) [28,85] | 37/61 (61) [47,73] |
| Consolidation ratio | 0.77 (0.64;0.90) | ≤13 | 36/49 (73) [59,85] | 8/12 (67) [35,90] | 44/61 (72) [59,83] |
GGO: ground glass opacity, SatO2: oxygen saturation, pO2: oxygen pressure.
Data in parentheses are 95% confidence intervals (CIs).
Data are numerators and denominators, with percentages in parentheses. Data in brackets are 95% CIs.
Clinical, demographic and CT features in dead and discharged patients
| Dead ( | Discharged ( | ||
|---|---|---|---|
| Sex, M | 9 (75%) | 34 (69%) | 1.00 |
| Age, years-old | 74 [69;81] | 53 [47;67] | 0.001 |
| Time from symptoms, days | 7 [2;7] | 7 [5;10] | 1.00 |
| SatO2 at admission, % | 90 [86;95] | 94 [90;96] | 1.00 |
| pO2 at admission, mm Hg | 59 [48;73] | 65[59;74] | 1.00 |
| Worst pO2 during hospitalization, mm Hg | 47 [36;56] | 65 [58;70] | <0.001 |
| Comorbidities, n° | 2 [1;4] | 1 [0;2] | 0.027 |
| Aerated lung, % | 45 [38;69] | 62 [51;77] | 0.898 |
| GGO, % | 9 [7;12] | 11 [8;14] | 1.00 |
| Semi-consolidation, % | 20 [13;28] | 16 [9;23] | 1.00 |
| Consolidation, % | 16 [11;26] | 7 [4;13] | 0.047 |
GGO: ground glass opacity, SatO2: oxygen saturation, pO2: oxygen pressure.
Multiple Cox's regression analysis including clinical, demographic and CT quantitative parameters of lung involvement for predicting patients' discharge
| Variables | Aerated lung ratio | GGO ratio | Semi-consolidation ratio | Consolidation ration | With all CT parameters | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||||
| sex M vs F | 0.24 (0.11–0.51) | <0.001 | 0.38 (0.20–0.72) | <0.01 | 0.37 (0.19–0.71) | <0.01 | 0.32 (0.16–0.62) | <0.001 | 0.26 (0.13–0.55) | <0.001 |
| Age, y.o. | 0.97 (0.95–0.99) | <0.01 | – | – | 0.97 | 0.02 | 0.97 (0.95–0.99) | <0.01 | 0.97 (0.94–0.99) | <0.01 |
| Time from symptoms onset | 1.07 (1.01–1.14) | 0.03 | – | – | – | – | – | – | 1.06 | 0.049 |
| SatO2, % | – | – | 1.02 (1.02–1.15) | <0.01 | – | – | – | – | ||
| Neoplasia | – | – | 0.32 (0.13–0.83) | 0.02 | – | – | 0.39 (0.15–0.99) | 0.049 | ||
| Aerated lung ≥ 45% | 3.93 (1.73–8.92) | <0.01 | – | – | – | – | – | – | ||
| CP ≤ 17% | – | – | – | – | 3.32 (1.76–6.27) | <0.001 | – | – | 2.60 (1.32–5.11) | <0.01 |
| Consolidation ≤ 13% | – | – | – | – | – | – | 3.42 (1.68–6.97) | <0.001 | 2.36 (1.12–5.00) | 0.03 |
GGO: ground glass opacity, SatO2: oxygen saturation, pO2: oxygen pressure, HR: Hazard ratio, CI: Confidence Interval.